Future Medicinal Chemistry

3.4(top 10%)

impact factor

1.9K(top 10%)

papers

52.3K(top 5%)

citations

92(top 5%)

h-index

4.3(top 10%)

impact factor

2.8K

all documents

55.5K

doc citations

137(top 5%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Biofilm formation mechanisms and targets for developing antibiofilm agents	Future Medicinal Chemistry	2015	492
2	Cannabinoids as novel anti-inflammatory drugs	Future Medicinal Chemistry	2009	385
3	Macrocycles in new drug discovery	Future Medicinal Chemistry	2012	362
4	Inhibition of Ras for cancer treatment: the search continues	Future Medicinal Chemistry	2011	349
5	Marine natural products: a new wave of drugs?	Future Medicinal Chemistry	2011	340
6	Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed	Future Medicinal Chemistry	2012	330
7	Strategies for discovering and derisking covalent, irreversible enzyme inhibitors	Future Medicinal Chemistry	2010	319
8	Fluorine in medicinal chemistry: a century of progress and a 60-year retrospective of selected highlights	Future Medicinal Chemistry	2009	304
9	Structural insights into G-quadruplexes: towards new anticancer drugs	Future Medicinal Chemistry	2010	295
10	Therapeutic potential of boron-containing compounds	Future Medicinal Chemistry	2009	279
11	Iminosugars as therapeutic agents: recent advances and promising trends	Future Medicinal Chemistry	2011	264
12	Therapeutic peptides	Future Medicinal Chemistry	2012	261
13	Carbonic anhydrase inhibitors and activators for novel therapeutic applications	Future Medicinal Chemistry	2011	260
14	Photoaffinity labeling in target- and binding-site identification	Future Medicinal Chemistry	2015	259
15	Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders	Future Medicinal Chemistry	2010	257
16	Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor	Future Medicinal Chemistry	2009	248
17	Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development	Future Medicinal Chemistry	2010	236
18	Atropisomerism in medicinal chemistry: challenges and opportunities	Future Medicinal Chemistry	2018	230
19	miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents	Future Medicinal Chemistry	2014	229
20	Agents that inhibit bacterial biofilm formation	Future Medicinal Chemistry	2015	226
21	An insight on bacterial cellular targets of photodynamic inactivation	Future Medicinal Chemistry	2014	224
22	Human copper transporters: mechanism, role in human diseases and therapeutic potential	Future Medicinal Chemistry	2009	222
23	Targeting protein–protein interactions for therapeutic intervention: a challenge for the future	Future Medicinal Chemistry	2009	221
24	Boron chemicals in diagnosis and therapeutics	Future Medicinal Chemistry	2013	208
25	miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart	Future Medicinal Chemistry	2015	196
26	The potentiality of vanadium in medicinal applications	Future Medicinal Chemistry	2012	194
27	Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications	Future Medicinal Chemistry	2014	191
28	Synthetic and natural iron chelators: therapeutic potential and clinical use	Future Medicinal Chemistry	2009	185
29	Drug-permeability and transporter assays in Caco-2 and MDCK cell lines	Future Medicinal Chemistry	2011	183
30	Conformational adaptation in drug–target interactions and residence time	Future Medicinal Chemistry	2011	177
31	Sulfonamides and their isosters as carbonic anhydrase inhibitors	Future Medicinal Chemistry	2014	172
32	Targeting cancer cell mitochondria as a therapeutic approach	Future Medicinal Chemistry	2013	170
33	Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments	Future Medicinal Chemistry	2009	163
34	Conformational restriction: an effective tactic in 'follow-on'-based drug discovery	Future Medicinal Chemistry	2014	163
35	Observations on screening-based research and some concerning trends in the literature	Future Medicinal Chemistry	2010	162
36	Magnetic iron oxide nanoparticles for biomedical applications	Future Medicinal Chemistry	2010	158
37	Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms	Future Medicinal Chemistry	2014	156
38	The PI3K/Akt/PTEN/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis?	Future Medicinal Chemistry	2015	155
39	JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases	Future Medicinal Chemistry	2015	153
40	Manufacturing peptides as active pharmaceutical ingredients	Future Medicinal Chemistry	2009	151
41	Antisense drug discovery and development	Future Medicinal Chemistry	2011	149
42	Sirtuin inhibitors as anticancer agents	Future Medicinal Chemistry	2014	148
43	Gallium-containing anticancer compounds	Future Medicinal Chemistry	2012	146
44	Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases	Future Medicinal Chemistry	2016	146
45	Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives	Future Medicinal Chemistry	2012	144
46	Thiosemicarbazones: the new wave in cancer treatment	Future Medicinal Chemistry	2009	141
47	N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs	Future Medicinal Chemistry	2015	141
48	Quercetin and derivatives: useful tools in inflammation and pain management	Future Medicinal Chemistry	2017	141
49	Software and resources for computational medicinal chemistry	Future Medicinal Chemistry	2011	140
50	Azapeptides and their therapeutic potential	Future Medicinal Chemistry	2011	140

Scientometrics

Overviews

Citing Bodies

Future Medicinal Chemistry

Top Articles